Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced positive results from a recently completed phase II clinical study of its ToleroMune(R) cat allergy therapy, which successfully identified the optimal dosing regimens to progress into late-stage development.




Circassia Announces Successful Results From Phase II Clinical Study Of ToleroMune(R) Cat Allergy Therapy



Sponsored by Indian Pharmacy, an Internet Pharmacy - online pharmacy supplies more than 600 high quality generic medications, at discounted prices, worldwide shipping.
xanax

Canadian Pharmacy the only canadian pharmacy offers Brand Hydrocodone Watson 540 and Oxycodone

Related posts:

  1. Alkermes Announces Initiation Of Phase 1 Clinical Study Of ALKS 37 For The Treatment Of Opioid-Induced Constipation
  2. Successful Phase III Clinical Trial Results Reported For NovoCure’s Novel Medical Device For Treatment Of Recurrent Glioblastoma
  3. PolyMedix Initiates Phase 1B Clinical Study With PMX-60056 To Reverse Low Molecular Weight Heparin


canadian pharmacy